Development and Validation of a Diagnostic DNA Microarray To Detect Quinolone-Resistant Escherichia coli among Clinical Isolates
暂无分享,去创建一个
Rolf D. Schmid | Till T. Bachmann | R. Schmid | T. Bachmann | M. Šuša | C. Knabbe | Cornelius Knabbe | Xiaolei Yu | Xiaolei Yu | Milorad Susa
[1] J. Smith. The mode of action of 4-quinolones and possible mechanisms of resistance. , 1986, The Journal of antimicrobial chemotherapy.
[2] A. Mirzabekov,et al. Detection of Rifampicin-Resistant Mycobacterium tuberculosis Strains by Hybridization and Polymerase Chain Reaction on a Specialized TB-Microchip , 2004, Bulletin of Experimental Biology and Medicine.
[3] I. Phillips,et al. Detection of ciprofloxacin resistance in gram-negative bacteria due to alterations in gyrA. , 1992, The Journal of antimicrobial chemotherapy.
[4] J. Yoo,et al. Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] S. Karlin,et al. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[6] P. Lu,et al. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center. , 2001, Microbial drug resistance.
[7] G. Jacoby. Mechanisms of resistance to quinolones. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] D. Hooper. Mechanisms of fluoroquinolone resistance. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[9] S. Nakamura,et al. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli , 1990, Antimicrobial Agents and Chemotherapy.
[10] K. Gunderson,et al. Mutation detection by ligation to complete n-mer DNA arrays. , 1998, Genome research.
[11] A. Mirzabekov,et al. Identification of Rifampin-Resistant Mycobacterium tuberculosis Strains by Hybridization, PCR, and Ligase Detection Reaction on Oligonucleotide Microchips , 2001, Journal of Clinical Microbiology.
[12] K U Mir,et al. Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. , 1994, Nucleic acids research.
[13] P. Heisig,et al. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli , 1996, Antimicrobial agents and chemotherapy.
[14] W. Fu,et al. Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. , 2002, The Journal of antimicrobial chemotherapy.
[15] A. Wyke,et al. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones , 1989, Antimicrobial Agents and Chemotherapy.
[16] W. Kern,et al. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. , 1996, The Journal of antimicrobial chemotherapy.
[17] D. Hooper,et al. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations , 1995, Antimicrobial agents and chemotherapy.
[18] J. Odeberg,et al. Genotyping by apyrase-mediated allele-specific extension. , 2001, Nucleic acids research.
[19] L. Gutmann,et al. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid , 1991, Antimicrobial Agents and Chemotherapy.
[20] I. Tinoco,et al. Base pairing involving deoxyinosine: implications for probe design. , 1985, Nucleic acids research.
[21] M. Drebot,et al. Design of oligonucleotide arrays to detect point mutations: molecular typing of antibiotic resistant strains of Neisseria gonorrhoeae and hantavirus infected deer mice. , 2003, Molecular and cellular probes.
[22] N. Moreau,et al. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition. , 1993, Journal of Antimicrobial Chemotherapy.
[23] G. Crumplin. Mechanisms of resistance to the 4-quinolone antibacterial agents. , 1990, The Journal of antimicrobial chemotherapy.
[24] S. Mitsuhashi,et al. Norfloxacin resistance in a clinical isolate of Escherichia coli , 1987, Antimicrobial Agents and Chemotherapy.
[25] D. Hooper,et al. Mechanisms of action of and resistance to ciprofloxacin. , 1987, The American journal of medicine.
[26] M. E. Cullen,et al. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. , 1989, The American journal of medicine.
[27] A. Khodursky,et al. Topoisomerase IV is a target of quinolones in Escherichia coli. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] John E. Linz,et al. Identification of Ciprofloxacin-ResistantCampylobacter jejuni by Use of a Fluorogenic PCR Assay , 2000, Journal of Clinical Microbiology.
[29] S. Levy,et al. Ineffectiveness of Topoisomerase Mutations in Mediating Clinically Significant Fluoroquinolone Resistance inEscherichia coli in the Absence of the AcrAB Efflux Pump , 2000, Antimicrobial Agents and Chemotherapy.
[30] L Peltonen,et al. Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. , 1997, Genome research.
[31] A. Troesch,et al. Mycobacterium Species Identification and Rifampin Resistance Testing with High-Density DNA Probe Arrays , 1999, Journal of Clinical Microbiology.
[32] L. Piddock,et al. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals , 1996, Antimicrobial agents and chemotherapy.
[33] E. Southern,et al. Molecular interactions on microarrays , 1999, Nature Genetics.
[34] C. Nusbaum,et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.
[35] P. Heisig,et al. Impact of gyrA and parCMutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia coli , 1999, Antimicrobial Agents and Chemotherapy.
[36] L. Ng,et al. Characterization of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates in Canada , 2002, Sexually transmitted diseases.
[37] P. Heisig,et al. Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[38] R. Hopewell,et al. New Concepts on the Mechanism of Action and Resistance , 1989 .